Compare · XPEL vs ZBH
XPEL vs ZBH
Side-by-side comparison of XPEL Inc. (XPEL) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- XPEL operates in Industrials, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $19.12B, about 13.8x XPEL ($1.38B).
- Over the past year, XPEL is up 32.5% and ZBH is down 6.2% - XPEL leads by 38.7 points.
- ZBH has been more active in the news (7 items in the past 4 weeks vs 4 for XPEL).
- ZBH has more recent analyst coverage (25 ratings vs 3 for XPEL).
- Company
- XPEL Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $50.54+0.61%
- $100.84+0.66%
- Market cap
- $1.38B
- $19.12B
- 1M return
- +15.18%
- +5.33%
- 1Y return
- +32.48%
- -6.21%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 4
- 7
- Recent ratings
- 3
- 25
XPEL Inc.
XPEL, Inc. manufactures, sells, distributes, and installs after-market automotive products in the United States, China, Canada, Continental Europe, the United Kingdom, Asia Pacific, Latin America, the Middle East/Africa, and internationally. The company offers automotive surface and paint protection, headlight protection, and automotive and architectural window films, as well as proprietary software. It also provides merchandise and apparel, and ceramic coatings. In addition, the company offers paint protection kits, car wash products, after-care products, and installation tools through its website. It sells its products to independent installers and new car dealerships, third party distributors, owned installation centers, and franchisees and online. The company was founded in 1997 and is headquartered in San Antonio, Texas.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest XPEL
- XPEL and Will Castro Return for Season 2 of 'Unique Academy USA,' Expanding Reach of Transformative Automotive Career Program
- SEC Form 10-Q filed by XPEL Inc.
- XPEL Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- XPEL Reports Record Revenue of $143.1 million; Revenue Growth of 14.7% in Second Quarter 2026
- SEC Form 4 filed by Director Thornton Mark Andrew
- XPEL Inc. filed SEC Form 8-K: Leadership Update
- XPEL, Inc. to Host Conference Call to Discuss Second Quarter 2026 Results
- Senior Vice President/CFO Wood Barry covered exercise/tax liability with 391 shares, was granted 968 shares and converted options into 637 shares, increasing direct ownership by 4% to 31,302 units (SEC Form 4)
- President and CEO Pape Ryan converted options into 1,990 shares, covered exercise/tax liability with 1,222 shares and was granted 3,026 shares, increasing direct ownership by 0.35% to 1,087,570 units (SEC Form 4)
- Director Bogart Stacy L converted options into 532 shares, increasing direct ownership by 7% to 8,466 units (SEC Form 4)
Latest ZBH
- Amendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 4 filed by President, APAC Desai Chintan
- SEC Form 10-Q filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Zimmer Biomet Announces Second Quarter 2026 Financial Results
- Grp Pres-Global Business Thornal Kevin R converted options into 9,957 shares and covered exercise/tax liability with 4,266 shares (SEC Form 4) (tax liability)
- UBS initiated coverage on Zimmer Biomet with a new price target
- SEC Form 3 filed by new insider Desai Chintan
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region